The Sigma‐2 Receptor/TMEM97 Agonist PB28 Suppresses Cell Proliferation and Invasion by Regulating the PI3K‐AKT‐mTOR Signalling Pathway in Renal Cancer-Reference-Cited by-同舟云学术

The Sigma‐2 Receptor/TMEM97 Agonist PB28 Suppresses Cell Proliferation and Invasion by Regulating the PI3K‐AKT‐mTOR Signalling Pathway in Renal Cancer

Published:2021-11-16 Issue:24 Volume:25 Page:11244-11256
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Zhan Bo¹,Zhang Zhe¹,Piao Chiyuan¹,Dong Xiao¹,Du Yang¹,Kong Chuize¹^ORCID,Jiang Yuanjun¹

Affiliation:

1. Department of Urology The First Hospital of China Medical University Shenyang People’s Republic of China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.17047

Reference29 articles.

1. The study on copy number alteration of clear cell renal cancer in Chinese population

2. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain

3. The effects of morphine‐ and nalorphine‐like drugs in the nondependent and morphine‐dependent chronic spinal dog;Martin WR;J Pharmacol Exp Ther,1976

4. Activation of Sigma Receptors With Afobazole Modulates Microglial, but Not Neuronal, Apoptotic Gene Expression in Response to Long‐Term Ischemia Exposure;Behensky AA;Front Neurosci,2019

5. Molecular Interplay Between the Sigma-1 Receptor, Steroids, and Ion Channels

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SPCS, a Novel Classifier System Based on Senescence Axis Regulators Reveals Tumor Microenvironment Heterogeneity and Guides Frontline Therapy for Clear Cell Renal Carcinoma;Clinical Genitourinary Cancer;2024-01

2. FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway;Cancer Cell International;2023-09-27

3. PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation;European Journal of Pharmacology;2023-09

4. Differential expression profile of urinary exosomal microRNAs in patients with mesangial proliferative glomerulonephritis;Aging;2023-02-14

5. Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects;Life Sciences;2022-11